[1]
“Stability indicating RP-HPLC method development and validation for the simultaneous estimation of ceftriaxone and tazobactum in sterile powder for injection”, Int. Jrnl.. Res. Pharm. Chem. & Analy, vol. 1, no. 2, pp. 40–43, Apr. 2019, Accessed: Sep. 06, 2025. [Online]. Available: https://rubatosis.org/journals/index.php/ijrpca/article/view/97